124 related articles for article (PubMed ID: 10815756)
1. Effects of galanin(1-16) on pancreatic secretion in anesthetized and conscious rats.
Takács T; Hegyi P; Czakó L; Baláspiri L; Lonovics J
Res Exp Med (Berl); 2000 Apr; 199(5):275-83. PubMed ID: 10815756
[TBL] [Abstract][Full Text] [Related]
2. Secretory capacity of pancreatic protein during luminal feedback regulation in conscious rats.
Okubo K; Masuda M; Miyasaka K; Funakoshi A
Jpn J Physiol; 1994; 44(2):205-19. PubMed ID: 7967222
[TBL] [Abstract][Full Text] [Related]
3. Effects of putative galanin antagonists M35 and C7 on rat exocrine pancreas.
Kisfalvi I; Rácz G; Bálint A; Máté M; Oláh A; Zelles T; Vizi ES; Varga G
J Physiol Paris; 2001; 95(1-6):385-9. PubMed ID: 11595464
[TBL] [Abstract][Full Text] [Related]
4. Effects of porcine galanin, galanin(1-15)NH2 and its new analogues on glucose-induced insulin secretion.
Ruczyński J; Cybal M; Wójcikowski C; Rekowski P
Pol J Pharmacol; 2002; 54(2):133-41. PubMed ID: 12139110
[TBL] [Abstract][Full Text] [Related]
5. Stimulatory and inhibitory effects of galanin on exocrine and endocrine rat pancreas.
Rünzi M; Müller MK; Schmid P; von Schönfeld J; Goebell H
Pancreas; 1992; 7(6):619-23. PubMed ID: 1280360
[TBL] [Abstract][Full Text] [Related]
6. Galanin inhibits pancreatic amylase secretion in the pentobarbital-anesthetized rat.
Yagci RV; Alptekin N; Zacharia S; Coy DH; Ertan A; Rossowski WJ
Regul Pept; 1991 Jul; 34(3):275-82. PubMed ID: 1718017
[TBL] [Abstract][Full Text] [Related]
7. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats.
Jyotheeswaran S; Li P; Chang TM; Chey WY
Pancreas; 2000 May; 20(4):401-7. PubMed ID: 10824696
[TBL] [Abstract][Full Text] [Related]
8. New galanin(1-15) analogues modified in positions 9, 10 and 11 act as galanin antagonists on glucose-induced insulin secretion.
Olkowicz M; Ruczyński J; Cybal M; Konstański Z; Petrusewicz J; Kamińska B; Rekowski P
J Physiol Pharmacol; 2007 Dec; 58(4):859-72. PubMed ID: 18195493
[TBL] [Abstract][Full Text] [Related]
9. Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats.
Yamazaki Y; Akahane M; Kobayashi M; Takeda H; Ajisawa Y
Jpn J Pharmacol; 1996 Feb; 70(2):183-90. PubMed ID: 8866756
[TBL] [Abstract][Full Text] [Related]
10. Effects of galanin on islet cell secretory responses to VIP, GIP, 8-CCK, and glucagon by the perfused rat pancreas.
Miralles P; Peiró E; Silvestre RA; Villanueva ML; Marco J
Metabolism; 1988 Aug; 37(8):766-70. PubMed ID: 2457142
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic secretory responses in L-arginine-induced pancreatitis: comparison of diabetic and nondiabetic rats.
Hegyi P; Czako L; Takacs T; Szilvassy Z; Lonovics J
Pancreas; 1999 Aug; 19(2):167-74. PubMed ID: 10438164
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pancreatic exocrine secretion by galanin.
Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
Pancreas; 1994 May; 9(3):297-303. PubMed ID: 7517543
[TBL] [Abstract][Full Text] [Related]
13. Galanin inhibits rat pancreatic amylase release via cholinergic suppression.
Flowe KM; Lally KM; Mulholland MW
Peptides; 1992; 13(3):487-92. PubMed ID: 1381828
[TBL] [Abstract][Full Text] [Related]
14. Galanin: structure-dependent effect on pancreatic amylase secretion and jejunal strip contraction.
Rossowski WJ; Zacharia S; Jiang NY; Mungan Z; Mills M; Ertan A; Coy DH
Eur J Pharmacol; 1993 Aug; 240(2-3):259-67. PubMed ID: 7694859
[TBL] [Abstract][Full Text] [Related]
15. Supramaximal CCK-58 does not induce pancreatitis in the rat: role of pancreatic water secretion.
Yamamoto M; Reeve JR; Green GM
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G964-74. PubMed ID: 17158258
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of galanin's inhibitory action on pancreatic enzyme secretion: modulation of cholinergic transmission--studies in vivo and in vitro.
Herzig KH; Brunke G; Schön I; Schäffer M; Fölsch UR
Gut; 1993 Nov; 34(11):1616-21. PubMed ID: 7694889
[TBL] [Abstract][Full Text] [Related]
17. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
[TBL] [Abstract][Full Text] [Related]
18. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas.
Kihara Y; Otsuki M
Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133
[TBL] [Abstract][Full Text] [Related]
19. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
